Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sequence‑dependent effect of sorafenib in combination with natural phenolic compounds on hepatic cancer cells and the possible mechanism of action
ABDUL-MAJEED BAHMAN, Mohamed Salah I. Abaza, Sarah Khoushiash, et al.
International Journal of Molecular Medicine (2018)
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment
Quan Gao, Jiao Feng, Wen‐Cheng Liu, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114445-114445
Closed Access | Times Cited: 169
Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma
Fanhua Kong, Qifa Ye, Xiongying Miao, et al.
Theranostics (2021) Vol. 11, Iss. 11, pp. 5464-5490
Open Access | Times Cited: 137
Targets Involved in the Anti-Cancer Activity of Quercetin in Breast, Colorectal and Liver Neoplasms
Alessandro Maugeri, Antonella Calderaro, Giuseppe Tancredi Patanè, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2952-2952
Open Access | Times Cited: 53
Harnessing the Power of Polyphenols: A New Frontier in Disease Prevention and Therapy
Mohamed El Oirdi
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 692-692
Open Access | Times Cited: 20
Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer
Sareshma Sudhesh Dev, Syafiq Asnawi Zainal Abidin, Reyhaneh Farghadani, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 96
Antitumor Effects of Quercetin in Hepatocarcinoma In Vitro and In Vivo Models: A Systematic Review
Paula Fernández‐Palanca, Flavia Fondevila, Carolina Méndez‐Blanco, et al.
Nutrients (2019) Vol. 11, Iss. 12, pp. 2875-2875
Open Access | Times Cited: 79
Molecular Pathways Involved in the Anti-Cancer Activity of Flavonols: A Focus on Myricetin and Kaempferol
Maria Rosa Felice, Alessandro Maugeri, Giovambattista De Sarro, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4411-4411
Open Access | Times Cited: 46
Combining Crocin and Sorafenib Improves Their Tumor-Inhibiting Effects in a Rat Model of Diethylnitrosamine-Induced Cirrhotic-Hepatocellular Carcinoma
Basma Awad, Alaaeldin Ahmed Hamza, Amna Al-Maktoum, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4063-4063
Open Access | Times Cited: 40
Combination Chemotherapy with Selected Polyphenols in Preclinical and Clinical Studies—An Update Overview
Cvijeta Jakobušić Brala, Ana Marković, Azra Kugić, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3746-3746
Open Access | Times Cited: 30
New pyrazolylindolin-2-one based coumarin derivatives as anti-melanoma agents: design, synthesis, dual BRAFV600E/VEGFR-2 inhibition, and computational studies
Ahmed Sabt, Mohammed A. Khedr, Wagdy M. Eldehna, et al.
RSC Advances (2024) Vol. 14, Iss. 9, pp. 5907-5925
Open Access | Times Cited: 9
Synergistic strategies for enhanced liver cancer therapy with sorafenib/resveratrol PEGylated liposomes in vitro and in vivo
Amal Abdullah Alrashidi, Seyed Zeinab Alavi, Maedeh Koohi Moftakhari Esfahani, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 96, pp. 105703-105703
Closed Access | Times Cited: 9
The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research
Na Song, Kai Cui, Ke Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
Application of Quercetin in the Treatment of Gastrointestinal Cancers
Seyed Mohammad Ali Mirazimi, Fatemeh Dashti, Mohammad Tobeiha, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylation
Aimei Liu, Qinghua Wu, Dapeng Peng, et al.
Medicinal Research Reviews (2020) Vol. 40, Iss. 5, pp. 1973-2018
Closed Access | Times Cited: 47
Lianhua Qingwen exerts anti-liver cancer effects and synergistic efficacy with sorafenib through PI3K/AKT pathway: Integrating network pharmacology, molecular docking, and experimental validation
Jinrui Wei, Xuqi Zhao, Fuli Long, et al.
Gene (2024) Vol. 912, pp. 148383-148383
Closed Access | Times Cited: 6
Design, Synthesis, Molecular Modeling, and Anticancer Evaluation of New VEGFR-2 Inhibitors Based on the Indolin-2-One Scaffold
Mohamed A. Abdelgawad, Alaa M. Hayallah, Syed Nasir Abbas Bukhari, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1416-1416
Open Access | Times Cited: 18
Enhancement of apoptosis in HCT116 and HepG2 cells by Coix lacryma-jobi var. lacryma-jobi seed extract in combination with sorafenib
Supawadee Parhira, Guo‐Yuan Zhu, Apirath Wangteeraprasert, et al.
Chinese Herbal Medicines (2025)
Open Access
Study on the mechanism by which Xuanfu Hua Tang increases sensitivity of hepatocellular carcinoma cells to sorafenib by antagonizing the Notch1 pathway through HIF-2α
Wen-Zhao Luo, Xian Li, Yi-Wan Shang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Novel 1,4‑naphthoquinone derivatives induce reactive oxygen species‑mediated apoptosis in liver cancer cells
Yue Wang, Ying‐Hua Luo, Xian‐Ji Piao, et al.
Molecular Medicine Reports (2018)
Open Access | Times Cited: 24
Methyl Palmitate—A suitable adjuvant for Sorafenib therapy to reduce in vivo toxicity and to enhance anti‐cancer effects on hepatocellular carcinoma cells
Raja David Isac Evangeline Breeta, V. M. Berlin Grace, Devarajan David Wilson
Basic & Clinical Pharmacology & Toxicology (2020) Vol. 128, Iss. 3, pp. 366-378
Closed Access | Times Cited: 22
Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells
Amna Mohamed Taha, Mohammad Aboulwafa, Hamdallah Zedan, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Non-cytotoxic levels of resveratrol enhance the anticancer effects of cisplatin by increasing the methyltransferase activity of CARM1 in human cancer cells
Xiao-Yun Zhao, Qiu-Hua Zhong, Heng Wee Tan, et al.
Phytomedicine (2024) Vol. 135, pp. 156127-156127
Closed Access | Times Cited: 2
Maximizing Polyphenol Content to Uncork the Relationship Between Wine and Cancer
Colin E. Champ, Anjali Kundu-Champ
Frontiers in Nutrition (2019) Vol. 6
Open Access | Times Cited: 19
Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid
Beste Yurdacan, Ünal Egelí, Gamze Güney Eskiler, et al.
Journal of Pharmacy and Pharmacology (2019) Vol. 71, Iss. 7, pp. 1119-1132
Open Access | Times Cited: 18
Resveratrol Promotes Tumor Microvessel Growth via Endoglin and Extracellular Signal-Regulated Kinase Signaling Pathway and Enhances the Anticancer Efficacy of Gemcitabine against Lung Cancer
Sanhai Qin, Andy T. Y. Lau, Zhan‐Ling Liang, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 974-974
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top